Should you buy BFRI stock?

Last updated:

Based on market data through , StockInvest.us rates Biofrontera Inc. (BFRI) as a Buy Candidate with a technical score of 4.55 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 14.81%
  • 3-month trend forecast Up 22.96%
  • Buy Candidate 4.55
AI Analysis AI Analysis of BFRI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BFRI to Watchlist?
Some Reasons Why To Add BFRI:
  • High gross margin of 82.8%
  • +71.0% YTD performance
  • Consistently positive technical signals over the last month
PDF

Biofrontera Inc. stock price ended at $1.24 on Wednesday, after gaining 1.64%
(Market data through Aug 05, 2026)

Buy or Hold candidate since Jul 21, 2026 Gain 14.81%

The Biofrontera Inc. stock price gained 1.64% on the last trading day (Wednesday, 5th Aug 2026), rising from $1.22 to $1.24. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.31% from a day low at $1.21 to a day high of $1.25. The price has risen in 7 of the last 10 days and is up by 14.81% over the past 2 weeks. Volume fell on the last day by -361 thousand shares and in total, 151 thousand shares were bought and sold for approximately $187.11 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.96% during the next 3 months and, with a 90% probability hold a price between $1.22 and $1.73 at the end of this 3-month period.

BFRI Signals & Forecast

The Biofrontera Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.19 and $1.08. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, May 21, 2026, and so far it has risen 59.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The stock had a Golden Star Signal on Friday, March 13, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, March 13, 2026 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Biofrontera Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.16 and $1.14. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biofrontera Inc. finds support just below today's level at $1.16. If this is broken, then the next support from accumulated volume will be at $1.14 and $1.11.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.31%. For the last week the stock has had daily average volatility of 6.79%.

Our recommended stop-loss: $1.20 (-3.22%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 51 days ago.)

Trading Expectations (BFRI) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Biofrontera Inc. to open at $1.23, and during the day (based on 14 day Average True Range), to move between $1.20 and $1.28, which gives a possible trading interval of +/-$0.0741 (+/-6.16%) up or down from last closing price. If Biofrontera Inc. takes out the full calculated possible swing range there will be an estimated 6.16% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.16, some $0.0800 (6.45%) from the current price of $1.24, our system finds the risk reward attractive.

Earnings coming up

Biofrontera Inc. will release earnings AMC on Wednesday, August 12, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.105. We will update the financials statements for Biofrontera Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 18.11% in the first trading day after earnings release.

Is Biofrontera Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biofrontera Inc. stock to perform well in the short-term.

Current score: 4.550 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $1.23 ( 0.538%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BFRI Performance

Trading levels for BFRI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.27 2.69%
R2 1.26 1.46%
R1 1.25 0.695%
Price 1.24
S1 1.22 -1.77%
S2 1.21 -2.53%
S3 1.19 -3.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 1.24
S1 1.16 -6.45%
S2 1.14 -8.06%
S3 1.11 -10.48%

FAQ

What is the symbol for Biofrontera Inc. Stock and on which exchange is it traded?
The symbol for Biofrontera Inc. is BFRI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biofrontera Inc. Stock?
Based on market data through Aug 05, 2026, StockInvest.us rates Biofrontera Inc. (BFRI) as a Buy Candidate with a technical score of 4.55 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jul 21, 2026, the price has risen 14.81%. The current 3-month trend forecast projects a rise of 22.96%.

How to buy Biofrontera Inc. Stock?
Biofrontera Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biofrontera Inc. Stock.

What's the current price of Biofrontera Inc. Stock?
As of the end of day on the Aug 05, 2026, the price of an Biofrontera Inc. (BFRI) share was $1.24.

What is the 52-week high and low for Biofrontera Inc. Stock?
The 52-week high for Biofrontera Inc. Stock is $1.27 and the 52-week low is $0.570.

What is the market capitalization of Biofrontera Inc. Stock?
As of the Aug 05, 2026, the market capitalization of Biofrontera Inc. is 15.876M.

When is the next earnings date for Biofrontera Inc.?
The upcoming earnings date for Biofrontera Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOFRONTERA INC.
Biofrontera
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-m...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE